Title Details

Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors

No-Receipt date

2015-02219 - 31/07/2015

No-Filing date

20150401616 - 31/07/2015

No-Granting date

3086696 - 31/08/2015

No-EPO application date

11152708.1 - 12/12/2006

No-EPO granting date

2348023 - 06/05/2015

Gazette No-Publication date of application

Gazette No-Publication date of granted patent

8/2015 - 29/09/2015

Expiration date

13/12/2026

Kind of title

Validation of European Patent

Legal status

VALID

Priorities

US749905 P13/12/2005/US
US810231 P02/06/2006/US
US850625 P10/10/2006/US
US856872 P03/11/2006/US
US859404 P16/11/2006/US

Active Substance of Supplementary Certificates

Ipc Class

C07D 487/04

C07D 471/04

A61P 17/00

A61K 31/395

A61P 37/00

A61P 35/00

Code

Firstname

Surname

Address

Town

ZIP

Country

743710

INCYTE HOLDINGS CORPORATION

1801 AUGUSTINE CUT-OFF

WILMINGTON, DE 19803

UNITED STATES OF AMERICA (USA)

Code

Firstname

Surname

1468751

RODGERS, JAMES D.

1468752

SHEPARD, STACEY

1468753

MADUSKUIE, THOMAS P.

1468754

WANG, HAISHENG

1468755

FALAHATPISHEH, NIKOO

1468756

RAFALSKI, MARIA

1468757

ARVANITIS, ARGYRIOS G.

1468758

STORACE, LOUIS

1468759

JALLURI, RAVI KUMAR

1468760

FRIDMAN, JORDAN S.

1468761

VADDI, KRISHNA

Code

Firstname

Surname

Address

Town

Zip

742

KONSTANTINOS

KILIMIRIS

XATZIGIANNI MEXI 7

ATHINA (ATTIKIS)

11528

Code

Firstname

Surname

Address

Town

Zip

Country

2119

KONSTANTINOS

KILIMIRIS

CHATZIGIANNI MEXI 7

ATHINA (ATTIKIS)

11528

GREECE

Date

Description

Comments

Data before modification

Data after modification

07/02/2017

Μεταβίβαση (7e802)

ΑΡ.ΠΡΩΤ.7151/22-12-16,ΔΝΥ158/17,ΚΩΔ.ΠΛΗΡ.3190(ΒΕΒΑΙΩΣΗ,βασει κοινοπ.ΕΓΔΕ,αριθμ.P056301EP/09.11.2015)

606025 Incyte Corporation 1801 Augustine Cut-Off ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Wilmington, DE 19803

743710 Incyte Holdings Corporation 1801 Augustine Cut-Off ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Wilmington, DE 19803

Date	Operation	Descreption
9/19/2024 12:00:00 AM	Διάφορες Μεταβολές (70004)	ΑΡ.ΠΡΩΤ. 23071/2024 (ΑΡ.ΥΠΟΘ. 3339/2024) ΠΛΗΡΕΞ. ΔΙΚΗΓΟΡΟΣ ΚΩΝ. ΚΙΛΙΜΙΡΗΣ (Η ΔΙΚΑΙΟΥΧΟΣ ΕΤΑΙΡΕΙΑ ΠΑΡΑΧΩΡΗΣΕ ΑΠΟΚΛΕΙΣΤΙΚΗ ΑΔΕΙΑ ΕΚΜΕΤΑΛΛΕΥΣΗΣ ΣΤΗΝ NOVARTIS PHARMA AG με έδρα την Lichtstrasse 35, 4056 Basel, SWITZERLAND)